期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

细胞工程与新型血液成分

在线阅读 下载PDF
导出
摘要 随着细胞工程技术的发展 ,血液中心或中心血站提供的血液成分越来越多、越来越复杂 ,不仅拓宽了移植用造血干细胞来源 ,还为过继性免疫治疗、基因治疗提供了可靠载体 ,为某些难治性疾病的治疗开创了新方法、新途径。
作者 王同显 刘勇立 赵林
机构地区 [
出处 《临床输血与检验》 CAS 2003年第4期310-312,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 细胞工程 血液成分 成分输血 造血干细胞 免疫治疗 基因治疗
分类号 Q813 [生物学—生物工程] R457 [医药卫生—治疗学]
  • 相关文献

参考文献15

  • 1沈柏均,刘星霞,鞠秀丽,张丽萍,侯怀水,马秀峰,时庆.MHC不相合的双份鼠胎血移植后受体鼠混合嵌合体形成(英文)[J].中国实验血液学杂志,2002,10(3):243-246. 被引量：5
  • 2Stroncek D, Anderlini P. Mobilized PBPC concentrates :a maturing blood component [J]. Transfusion, 2001,41(2):168-171.
  • 3To LB,Haylock DN,Simmons PJ, et al. The biology and clinical uses of blood stem cells[J]. Blood, 1997,89(6) : 2233-2258.
  • 4Piacibello W, Sanavio F,Garetto L,et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood[J]. Blood,1997,89 (6) : 2664-2653.
  • 5Emerson SG. Ex vivo expansion of hematopoietic precursors ,progenitors, and stem cells :the next generation of cellular therapies [J]. Blood, 1996, 87 (7): 3082-3O88.
  • 6Kolb HJ,Holler E. Adoptive immunotherapy with donor lymphocyte transfusion [J]. Curr Opin Oncol, 1997, 9(1) :139-145.
  • 7Alyea EP,Soiffer RJ ,Canning C ,et al. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse allogeneic bone marrow transplant[J]. Blood, 1998,91, (10) : 3671-3680.
  • 8Slavini S, Naparstek E, Nagler A,et al. Allogeneic cell therapy:the treatment of choice for all hematologic malignancies replasing post BMT[J]. Blood, 1996,87 (8) :4011-4013.
  • 9Ricordi C, Karatzas T,Nery J,et al. High dose donor bone marrow infusion to enhance allograft survival[J].Transplant, 1997,63 (1) : 7-11.
  • 10Pham SM, Rao AS, Zeevi A, et al. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results[J]. Thorac Cardiovasc Surg, 2000,119 (2) : 673-680.

二级参考文献10

  • 1Gluckman E, Broxmeyer HA, AuerbachAD, et al. Hematopoietic reconstitution in a patiant with Fanconi's anemia by means ofumbilical cord blood from an HLA-identical sibling. N Engl J Med, 1989;321:1174 - 1178
  • 2Hows JM: Status of umbilical cord blood transplantation in the year 2001. J ClinPathol 2001; 54:428 - 434
  • 3Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells fromcultured human perimordial germ cells. Proc Natl Acad Sci, USA. 1998; 95:13726- 13731
  • 4Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derivedfrom human blastocysts. Science, 1998; 282(5391): 1145 - 1147
  • 5Roncarolo MG, Bigler M, Martino S, et al. Immune functions of cord blood cellsbefore and after transplantation. J Hematother,1996; 5:157- 160
  • 6Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival inadult recipients of umbilical-cord blood from unrelated donors. N Engl J Med, 2001;344:1815- 1822
  • 7Chen BJ, Cui XY, Chao NJ. Addition of stem cells from allogenic donors acceleratesengraftment and immune reconstitution after atem cell transplantation. Blood, 2000; 96 (11, Part 1 ): 172a ( Abstract# 739)
  • 8Risdon G, Gaddy J, Broxmeyer HE. Allogeneic responses of human umbilical cordblood. Blood Cells, 1994; 20:566- 570
  • 9Shen BJ, Hou HS, Zhang HQ, et al. Unrelated HLA-mismatched multiple humanumbililcal cord blood transplantation in four caded with advanced solid tumors: Initialstudies. Blood Cells, 1994; 20:285 - 292
  • 10Shen BJ, Ceng FH, Wang HM, et al. A study of placenta hematopoiesis. Blood, 1998;92 ( 10, suppl. 2): 360

共引文献4

临床输血与检验
2003年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部